anmelden
SMI Expanded
1.972,28
PKT
-10,97
PKT
-0,55
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.07.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 26.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.22 | UBS Outperform | RBC Capital Markets | |
| 25.07.22 | Richemont Buy | UBS AG | |
| 25.07.22 | Givaudan Hold | Deutsche Bank AG | |
| 25.07.22 | Roche Neutral | Credit Suisse Group | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 22.07.22 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 22.07.22 | Roche Hold | Deutsche Bank AG | |
| 22.07.22 | Givaudan Sell | UBS AG | |
| 22.07.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 22.07.22 | Givaudan Add | Baader Bank | |
| 22.07.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Nestlé Market-Perform | Bernstein Research | |
| 22.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.07.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 21.07.22 | ABB (Asea Brown Boveri) Buy | UBS AG | |
| 21.07.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.07.22 | Givaudan Sell | UBS AG | |
| 21.07.22 | Roche Neutral | UBS AG | |
| 21.07.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 21.07.22 | ABB (Asea Brown Boveri) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.07.22 | Roche Outperform | Bernstein Research | |
| 21.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 21.07.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Givaudan Underperform | Bernstein Research | |
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 21.07.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.07.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Roche Hold | Deutsche Bank AG | |
| 20.07.22 | Novartis Sell | Deutsche Bank AG | |
| 20.07.22 | Swiss Re Equal Weight | Barclays Capital | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |
